TSE:4929 stock news
This page provides real-time market news, earnings updates, and company announcements related to ADJUVANT HOLDINGS CO., LTD. (TSE:4929).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-22 13:58 JST
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Finviz2026-02-13 16:51:41
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients
Finviz2026-02-17 11:43:26
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 13:03:48
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Finviz2026-02-26 21:09:42
Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?
Finviz2026-02-27 04:54:43
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
Finviz2026-02-27 13:33:07
Novavax Shares Rise After Surpassing Q4 Earnings and Revenue Expectations
101 finance2026-02-27 14:33:35
H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod
Finviz2026-03-02 15:24:37
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Finviz2026-03-02 21:09:43
Merck’s Keytruda Fuels Projected Revenue Growth for 2025: What Lies Ahead?
101 finance2026-03-03 16:10:08
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch
Finviz2026-03-04 16:42:46
Merck's Modest 0.38% Gain on 140th-Ranked Volume as Oncology Pipeline and Strategic Shifts Shape Investor Caution
101 finance2026-03-04 23:03:47
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate
Finviz2026-03-08 16:51:49
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
Finviz2026-03-09 11:03:47
50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today
Finviz2026-03-09 23:00:57
RLMD Shares Jump 42% Over the Past Week: Key Information You Need
101 finance2026-03-12 18:09:48
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Finviz2026-03-12 20:09:51
JNJ's Treatment for Bladder Cancer Achieves Primary Objective in Initial Phase Trial
101 finance2026-03-16 18:13:03
Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01
Finviz2026-03-17 10:03:49
Elicio Therapeutics Reports Inducement Grants
Finviz2026-03-17 12:03:53
Breakthrough in Clinical Trial Data: Biopharmaceutical company Greenwich Lifesciences Inc (NASDAQ: GLSI) recently announced the latest analysis results of its core immunotherapy GP2 in adjuvant treatment for breast cancer.
老虎证券2026-03-18 10:24:33
Puma Biotechnology Shares Drop Over 9% in the Past Month: Reasons Explained
101 finance2026-03-18 16:37:07
Relmada Therapeutics Inc.'s 2025 Q4 Call: 12-Month Data Timing, Phase 3 Enrollment, and R&D Cost Signals Don’t Match
101 finance2026-03-19 22:43:39
Relmada (RLMD) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-19 23:48:56
Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?
Finviz2026-02-27 04:54:43
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
Finviz2026-02-27 13:33:07
Novavax Shares Rise After Surpassing Q4 Earnings and Revenue Expectations
101 finance2026-02-27 14:33:35
H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod
Finviz2026-03-02 15:24:37
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Finviz2026-03-02 21:09:43
Merck’s Keytruda Fuels Projected Revenue Growth for 2025: What Lies Ahead?
101 finance2026-03-03 16:10:08
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch
Finviz2026-03-04 16:42:46
Merck's Modest 0.38% Gain on 140th-Ranked Volume as Oncology Pipeline and Strategic Shifts Shape Investor Caution
101 finance2026-03-04 23:03:47
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate
Finviz2026-03-08 16:51:49
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
Finviz2026-03-09 11:03:47
50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today
Finviz2026-03-09 23:00:57
RLMD Shares Jump 42% Over the Past Week: Key Information You Need
101 finance2026-03-12 18:09:48
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Finviz2026-03-12 20:09:51
JNJ's Treatment for Bladder Cancer Achieves Primary Objective in Initial Phase Trial
101 finance2026-03-16 18:13:03
Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01
Finviz2026-03-17 10:03:49
Elicio Therapeutics Reports Inducement Grants
Finviz2026-03-17 12:03:53
Breakthrough in Clinical Trial Data: Biopharmaceutical company Greenwich Lifesciences Inc (NASDAQ: GLSI) recently announced the latest analysis results of its core immunotherapy GP2 in adjuvant treatment for breast cancer.
老虎证券2026-03-18 10:24:33
Puma Biotechnology Shares Drop Over 9% in the Past Month: Reasons Explained
101 finance2026-03-18 16:37:07
Relmada Therapeutics Inc.'s 2025 Q4 Call: 12-Month Data Timing, Phase 3 Enrollment, and R&D Cost Signals Don’t Match
101 finance2026-03-19 22:43:39
Relmada (RLMD) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-19 23:48:56
TSE:4929 stock price change
On the last trading day, TSE:4929 stock closed at 760.00 JPY, with a price change of -0.78% for the day.
Trade stock perpsTSE:4929 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more